Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment OptionsAxel C Mühlbacher, Andrew SadlerGesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 20, 2017
[The Probabilistic Efficiency Frontier: A Value Assessment of Treatment Options in Hepatitis C]Axel C Mühlbacher, Andrew SadlerThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 9, 2022
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economicsAxel C Mühlbacher, Andrew Sadler, Yvonne JordanThe Patient|November 28, 2023
Preferences for Monitoring Comprehensive Heart Failure Care: A Latent Class AnalysisAxel C Mühlbacher, Andrew Sadler, Christin JuhnkeThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2021
Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experimentAxel C Mühlbacher, Andrew Sadler, Christin JuhnkeTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 17, 2018
Incentives for Blood Donation: A Discrete Choice Experiment to Analyze Extrinsic MotivationAndrew Sadler, Ling Shi, Susanne Bethge, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2026
Understanding Preference Heterogeneity in Digital Neurorehabilitation: Results of a Discrete Choice ExperimentAnn-Kathrin Fischer, Andrew Sadler, Thomas Kohlmann, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 9, 2020
Patient Preferences in the Treatment of Hemophilia A: A Best-Worst Scaling Case 3 AnalysisAxel C Mühlbacher, Andrew Sadler, Björn Lamprecht, et al.Plos One|September 15, 2025
Analysis of patients preferences in type 2 diabetes mellitus second-line drug treatment: A discrete choice experimentAnn-Kathrin Fischer, Andrew Sadler, Elke Mathey, et al.Plos One|August 23, 2021
Patient preferences in the treatment of hemophilia A: A latent class analysisAxel C Mühlbacher, Andrew Sadler, Björn Lamprecht, et al.Pageof 2